Seth Lederman

Seth Lederman is co-founder, CEO and chairman of Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company dedicated to the development of novel medicines for disorders of the central nervous system, including fibromyalgia, post-traumatic stress disorder (PTSD), and episodic tension-type headache.

Content by Seth Lederman:

Discovery & Development Trends & Forecasts

Big Diseases in a Small World

12/14/2022 | Seth Lederman | 5 min read

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world

Business & Regulation Business Practice

The Big Leap from Academic to Entrepreneur

05/05/2015 | Seth Lederman

To launch a new company, you’ll need great science…and great perseverance.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine